Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research

Molecular targeted therapy: treating cancer with specificity

(2018) Yeuan Ting Lee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival

(2018) Arian Lasocki et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Glioma infiltration sign on high b-value diffusion-weighted imaging in gliomas and its prognostic value

(2018) Qiang Zeng et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Differentiation between vasogenic edema and infiltrative tumor in patients with high-grade gliomas using texture patch-based analysis

(2018) Moran Artzi et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome

(2018) Aikaterini Kotrotsou et al.   JOURNAL OF NEURO-ONCOLOGY

Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686

(2018) Jerrold L Boxerman et al.   NEURO-ONCOLOGY

Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma

(2017) Arian Lasocki et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience

(2017) Federico Pessina et al.   JOURNAL OF NEURO-ONCOLOGY

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

(2017) Michael Weller et al.   LANCET ONCOLOGY

Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology

(2017) Oliver Eidel et al.   PLoS One

Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implications

(2016) Arian Lasocki et al.   JOURNAL OF CLINICAL NEUROSCIENCE

The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma

(2016) Arian Lasocki et al.   JOURNAL OF NEURO-ONCOLOGY

The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?

(2016) Yan Michael Li et al.   JOURNAL OF NEUROSURGERY

The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab

(2015) R. Y. Huang et al.   CLINICAL CANCER RESEARCH

Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma

(2015) Arian Lasocki et al.   Journal of Medical Imaging and Radiation Oncology

Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool

(2015) William Omar Lopez et al.   OncoTargets and Therapy

Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma

(2015) Leland S. Hu et al.   PLoS One

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma

(2014) Matthew M. Grabowski et al.   JOURNAL OF NEUROSURGERY

Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma

(2014) M. Nowosielski et al.   NEUROLOGY

An Intra-Individual Comparison of MRI, [18F]-FET and [18F]-FLT PET in Patients with High-Grade Gliomas

(2014) Martha Nowosielski et al.   PLoS One

Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas

(2014) Anne L. Baldock et al.   PLoS One

Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor

(2014) Rajan Jain et al.   RADIOLOGY

Brain Tumors

(2013) Lara A. Brandão et al.   Magnetic Resonance Imaging Clinics of North America

IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection

(2013) Jason Beiko et al.   NEURO-ONCOLOGY

Intraoperative Fluorescence-Guided Resection of High-Grade Malignant Gliomas Using 5-Aminolevulinic Acid–Induced Porphyrins: A Systematic Review and Meta-Analysis of Prospective Studies

(2013) Shiguang Zhao et al.   PLoS One

Relationship between Tumor Enhancement, Edema,IDH1Mutational Status,MGMTPromoter Methylation, and Survival in Glioblastoma

(2012) J.A. Carrillo et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

The Value of Glioma Extent of Resection in the Modern Neurosurgical Era

(2012) Douglas A. Hardesty et al.   Frontiers in Neurology

Isolated Diffusion Restriction Precedes the Development of Enhancing Tumor in a Subset of Patients with Glioblastoma

(2011) A. Gupta et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

(2011) L.C. Hygino da Cruz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Awake surgery for WHO Grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection

(2011) Yordanka N. Yordanova et al.   JOURNAL OF NEUROSURGERY

Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review

(2011) Pieter L Kubben et al.   LANCET ONCOLOGY

Apparent Diffusion Coefficient of Glial Neoplasms: Correlation with Fluorodeoxyglucose–Positron-Emission Tomography and Gadolinium-Enhanced MR Imaging

(2010) A.I. Holodny et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Correlation of MR Relative Cerebral Blood Volume Measurements with Cellular Density and Proliferation in High-Grade Gliomas: An Image-Guided Biopsy Study

(2010) S.J. Price et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

(2010) Benjamin M. Ellingson et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Radiographic patterns of relapse in glioblastoma

(2010) Marc C. Chamberlain   JOURNAL OF NEURO-ONCOLOGY

Differential diagnosis by unenhanced FLAIR T2-weighted magnetic resonance images between solitary high grade gliomas and cerebral metastases appearing as contrast-enhancing cortico-subcortical lesions

(2010) Carmine Franco Muccio et al.   JOURNAL OF NEURO-ONCOLOGY

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Grade Gliomas: Do Changes in rCBV Measurements at Longitudinal Perfusion-weighted MR Imaging Predict Malignant Transformation?

(2009) Nasuda Danchaivijitr et al.   RADIOLOGY

Multicentric/multifocal cerebral lesions: Can fluid-attenuated inversion recovery aid the differentiation between glioma and metastases?

(2008) SL Stuckey et al.   Journal of Medical Imaging and Radiation Oncology